Company: KCHVR
Filing Date: 2025-07-09
Form Type: 10-Q
Source: 0001213900-25-062351
Chunk: 66

Company: Kochav Defense Acquisition Corp.
Filing Date: 2025-07-09
Form: 10-Q
Item: Part I, Item 8
Chunk 66
---
 our sponsor paid approximately $0.003 per founder
share. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of
the Securities Act. No underwriting discounts or commissions were paid with respect to such issuances. The founder shares are automatically
convertible into Class A ordinary shares concurrently with or immediately following the consummation of our initial Business Combination,
or earlier at the option of the holder, on a one-for-one basis, subject to adjustment.

Subsequent to the quarterly period covered by
this Report, on May 29, 2025, the Company consummated its Initial Public Offering of 25,300,000 Units, including the exercise in
full by the underwriters of an option to purchase up to 3,300,000 Units at the offering price to cover over-allotments. The Units were
sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $253,000,000. Simultaneously with the closing of the IPO,
pursuant to the Sponsor Private Placement Units Purchase Agreement, the Company completed the private sale of an aggregate of 524,050
Private Placement Units to the Sponsor at a price of $10.00 per Private Placement Unit. The Private Placement Units (and underlying securities)
are identical to the units included in the Units sold in the IPO, except as otherwise disclosed in the Company’s Registration Statement.
No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant
to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Use of Proceeds

Following the closing of our Initial Public Offering on May 29, 2025, a total of $253,000,000 of the proceeds from the IPO and the sale
of the Private Placement Units (which amount includes up to $6,957,500 in the aggregate of the representative’s deferred underwriting
commissions), was placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee.
The proceeds held in the Trust Account may be invested by the trustee only in U.S. government securities with a maturity of 185 days or
less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7
under the Investment Company Act. To mitigate the risk that we might